-1495126649.jpg)
Industry leaders agree to implement UN agency's standards on clinical trial reporting
“Research funders are making a strong statement that there will be no more excuses on why some clinical trials remain unreported long after they have completed,” said Marie-Paule Kieny, Assistant Director-General for Health Systems and Innovation at the UN World Health Organization (WHO).
The concern is that unreported trials result in an “incomplete and potentially misleading” understanding of the risks and benefits of vaccines, drugs and medical devices, and could lead to the release of harmful products.
The standards are based on a 2015 WHO published position on public disclosure, which defines timeframes within which the results should be reported.
On Thursday's joint statement that future standards will be in line with that 2015 position, was signed by the Indian Council of Medical Research, the Norwegian Research Council, the UK Medical Research Council, Médecins Sans Frontières and Epicentre (its research arm), PATH, the Coalition for Epidemic Preparedness Innovations (CEPI), Institut Pasteur, the Bill & Melinda Gates Foundation, and the Wellcome Trust.
According to a press release, the entities agreed to develop and implement policies within the next 12 months that require all trials they fund, co-fund, sponsor or support to be registered in a publicly-available registry.
Photo: World Bank
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
